RGS16 Inhibits Breast Cancer Cell Growth by Mitigating Phosphatidylinositol 3-Kinase Signaling
Open Access
- 7 August 2009
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 284 (32), 21719-21727
- https://doi.org/10.1074/jbc.m109.028407
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Overexpression of Akt converts radial growth melanoma to vertical growth melanomaJCI Insight, 2007
- Active Gαq subunits and M3 acetylcholine receptors promote distinct modes of association of RGS2 with the plasma membraneFEBS Letters, 2007
- Activation of Akt Predicts Poor Outcome in NeuroblastomaCancer Research, 2007
- Multidrug resistance-associated protein 1 expression is under the control of the phosphoinositide 3 kinase/Akt signal transduction network in human acute myelogenous leukemia blastsLeukemia, 2007
- Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Nature, 2007
- The Epidermal Growth Factor Receptor Pathway: A Model for Targeted TherapyClinical Cancer Research, 2006
- Mammalian RGS proteins: Multifunctional regulators of cellular signallingSeminars in Cell & Developmental Biology, 2006
- Activation of PI3K/Akt signaling and hormone resistance in breast cancerBreast Cancer, 2006
- Differential responses to doxorubicin-induced phosphorylation and activation of Akt in human breast cancer cellsBreast Cancer Research, 2005
- Cellular survival: a play in three AktsGenes & Development, 1999